Leaching of 210Po in human saliva from smokeless tobacco

Syed, Umme-Farzana; Bari, Abdul; Husain, Liaquat
September 2009
Journal of Radioanalytical & Nuclear Chemistry;Sep2009, Vol. 281 Issue 3, p541
Academic Journal
Use of smokeless tobacco (SLT) is associated with cancer of the oral cavity. 210Po, a known carcinogen present in SLT may leach into the saliva when the snuff is held in the mouth. Alpha emission from leached 210Po can cause oral tissue damage, especially in the presence of non healing ulcers seen frequently in snuff users’ mouth. Leaching of 210Po from SLT in human saliva was determined for six popular US snuff brands. 210Po was leached into human saliva for 30 min, separated radiochemically and its activity was determined by α-counting. Approximately 2–10% of 210Po present in SLT was observed to leach. Annual exposure from leached 210Po, based on average daily consumption of 15 g of SLT, was calculated to range from 1.1 to 3.8 Bq year−1.


Related Articles

  • Levels of toxins in oral tobacco products in the UK. McNeil, A.; Bedi, R.; Islam, S.; Alkhatib, M. N.; West, R. // Tobacco Control;Feb2006, Vol. 15 Issue 1, p64 

    Objective: This study examined the constituents of smokeless tobacco products available in the UK and compared them with products available in India, Sweden, and the USA Methods: Seven UK brands of smokeless tobacco, including a tooth cleaning powder, and four international brands of smokeless...

  • Smokeless Tobacco and Head and Neck Cancer: There is Risk Even Without Fire. Lee, John H. // South Dakota Medicine;2009 Supplement, p38 

    The use of smokeless tobacco (primarily moist chewing tobacco) is currently on the rise in the USA. Smokeless tobacco contains many carcinogens. Multiple large-scale epidemiologic studies have been completed to evaluate the risk of cancer associated with use of smokeless tobacco. This article...

  • Smokeless Tobacco and Cancer: Questions and Answers.  // Smokeless Tobacco & Cancer: Questions & Answers;5/30/2003, p1 

    The article discusses the association between smokeless tobacco and cancer. There are two types of smokeless tobacco. First is snuff, which is a shredded tobacco sniffed through the nose or placed between the cheek and gum. Chewing tobacco is another, which is used by putting a wad of tobacco...

  • For the record.  // New Scientist;9/19/2009, Vol. 203 Issue 2726, p27 

    The article presents several corrections, including one on carcinogen content in the smokeless tobacco product in the August 22, 2009 issue and another on Changfeng Chen's university in the September 5, 2009 issue.

  • Using Tobacco to Stop Smoking: Low-Carcinogen Smokeless Product Could Help Millions Quit Cigarettes, Experts Say.  // Ascribe Newswire: Health;11/15/2005, p2 

    The article informs that low-carcinogen smokeless product could help millions quit cigarettes. About 4 million fewer Americans would smoke cigarettes with the proper marketing of a low-carcinogen smokeless tobacco that's popular in Europe, according to a recently published report. Researchers...

  • A novel model mouth system for evaluation of In Vitro release of nicotine from moist snuff. Peng Li; Jie Zhang; Shi-Hao Sun; Jian-Ping Xie; Yong-Li Zong // Chemistry Central Journal;2013, Vol. 7 Issue 1, p1 

    Background Pouch moist snuff, as a form of oral smokeless tobacco products, is becoming increasingly popular in North America, Scandinavia (where it is known as Snus), South Asia and parts of Africa. User usually places a pouch between the upper jaw and cheek to obtain euphoria from tobacco,...

  • Swedish moist snuff accelerates gastric cancer development in Helicobacter pylori-infected wild-type and gastrin transgenic mice. Björn Stenström; Chun-Mei Zhao; Arlin B. Rogers; Hans-Olof Nilsson; Erik Sturegård; Steinar Lundgren; James G. Fox; Timothy C. Wang; Torkel M. Wadström; Duan Chen // Carcinogenesis;Sep2007, Vol. 28 Issue 9, p2041 

    The Swedish variant of moist oral smokeless tobacco (snus) is popular in Sweden and Norway, banned from sale within the European Union and is currently being introduced in USA. The aim of the present study was to determine if snus is carcinogenic to the stomach, particularly in Helicobacter...


    In the United States, smokeless tobacco (ST) is marketed as chewing tobacco and as oral snuff. During the past 15 years, consumption of chewing tobacco has declined by 30.6%, whereas snuff use has significantly increased, namely, by 51.8%. This increase is primarily due to the growing popularity...

  • Smokeless tobacco topography and toxin exposure. Lemmonds, Charlotte A.; Hecht, Stephen S.; Jensen, Joni A.; Murphy, Sharon E.; Carmella, Steven G.; Yan Zhang; Hatsukami, Dorothy K. // Nicotine & Tobacco Research;Jun2005, Vol. 7 Issue 3, p469 

    This study examined the relationship between oral smokeless tobacco (ST) topographical measures and biomarkers of tobacco and carcinogen exposure. During 2 weeks of baseline ad libitum ST use, 54 male participants (mean age = 32.1±7.5 years) were required to record the time each dip was...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics